HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$2.75
Day range
$2.75 - $2.97
Year range
$1.88 - $7.22
Market cap
84.49M USD
Avg Volume
121.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.01M | 1.39% |
Net income | -21.73M | 1.25% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 54.12M | -49.07% |
Total assets | 55.72M | -48.95% |
Total liabilities | 8.10M | -3.83% |
Total equity | 47.63M | — |
Shares outstanding | 30.17M | — |
Price to book | 1.74 | — |
Return on assets | -90.76% | — |
Return on capital | -105.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -21.73M | 1.25% |
Cash from operations | -16.66M | -43.21% |
Cash from investing | 16.14M | 318.19% |
Cash from financing | -89.60K | — |
Net change in cash | -602.47K | 92.25% |
Free cash flow | -16.88M | -6.67% |
About
Headquarters
Website
Employees
20
